Heart Valve Market, By Type (Mechanical Heart Valves (Aortic Valves and Mitral Valves), Biological Heart Valves (Aortic Valves, Mitral Valves, Pulmonary Valves, and Tricuspid Valves), and Transcatheter Heart Valves (Aortic Valves, Mitral Valves, and Pulmonary Valves)), By End User (Hospitals and Ambulatory Surgical Center), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) - Trends, Analysis and Forecast till 2034

The heart valve market, estimated at US$12 billion in 2024, is expected to expand at a compound annual growth rate (CAGR) of 11.8% to US$33.3 billion by 2034.

Heart valves are essential to the cardiovascular system because they maintain the blood's unidirectional flow through the heart and into the main blood vessels. However, several conditions, including age, degenerative illnesses, infections, and congenital abnormalities, can cause heart valves to malfunction or sustain damage, impairing their capacity to control blood flow properly. In these situations, heart valve replacement surgery is required to return the heart to normal function and avoid complications such as stroke or heart failure. A prosthetic valve is installed in place of the damaged or diseased valve during this surgical procedure. There are two main categories of prosthetic heart valves: biological and mechanical. Most mechanical heart valves are made of strong materials like carbon or titanium, which have great longevity and resistance to deterioration. They are less likely to deteriorate over time and regulate blood flow effectively.